Filters:
Investigator: Mark Gurney1 Projects | 1 Researchers | $953,518 Invested
2016
Tetra Therapeutics Inc.
Mark Gurney, PhD
BPN14770 Safety and Cognitive Benefit in Young and Elderly Subjects
Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.
Mark Gurney, PhD
BPN14770 Safety and Cognitive Benefit in Young and Elderly Subjects